2018 Global Healthcare Licensing - Trends: By Industry (Pharmaceuticals) Mid-Year Review - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Aug 21, 2018--The “Global Healthcare Licensing - Global Trends: By Industry (Pharmaceuticals) Mid-Year Review” report has been added to ResearchAndMarkets.com’s offering.
This mid-year review report provides comprehensive analysis on all such licensing deals and negotiations that took place between global pharmaceuticals companies during January 1, 2018 to June 30, 2018, categorized and summarized by various important aspects such as key countries, across key regions, market capitalization groups, medicine groups, licensing payment arrangements, worldwide vs domestic licensing, and R&D vs commercialization licensing.
Such detailed analysis helps to understand the licensing trends and directions during this time period in the global pharmaceuticals sector.
Key Features6 months’ licensing transactions for global pharmaceuticals sector analyzed at one place Small, medium and big multinational/non-multinational companies covered Curated categorizations of licensing details 8+ variables reflecting different forms of transactions done Licensing trends and directions summarized
Key Analysis Provided (January-June 2018)Total number of licensing deals signed in the global pharmaceuticals sector Total number of companies/institutes involved in the licensing deals for global pharmaceuticals sector Most licensing deals signed by which country’s pharmaceuticals companies Most licensing deals signed by which market capitalization group’s pharmaceuticals companies Most licensing deals signed by which medicine groups for global pharmaceuticals sector Licensing payment arrangements most followed in the licensing deals for global pharmaceuticals sector Number of domestic and worldwide licensing in global pharmaceuticals sector Number of R&D and commercialization licensing in global pharmaceuticals sector
For more information about this report visit https://www.researchandmarkets.com/research/5ntst7/2018_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180821005445/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Healthcare Services
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/21/2018 10:18 AM/DISC: 08/21/2018 10:18 AM